Macis, Debora <br/><br/>
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2012 
 - 151-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2011.35.2237  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--blood<br/>Anticarcinogenic Agents--therapeutic use<br/>Breast Neoplasms--blood<br/>Double-Blind Method<br/>Female<br/>Fenretinide--administration & dosage<br/>Humans<br/>Leptin--blood<br/>Middle Aged<br/>Premenopause--blood<br/>Prognosis<br/>Risk Factors<br/>Tamoxifen--administration & dosage